AS
Altshuler Shaham Portfolio holdings
AUM
$3.14B
1-Year Return
24.55%
This Quarter Return
+3.42%
1 Year Return
+24.55%
3 Year Return
+51.84%
5 Year Return
+71.45%
10 Year Return
–
AUM
$9.74B
AUM Growth
+$4.74B
(+95%)
Cap. Flow
+$4.51B
Cap. Flow
% of AUM
46.35%
Top 10 Holdings %
Top 10 Hldgs %
64.11%
Holding
550
New
164
Increased
124
Reduced
128
Closed
110
Top Buys
| 1 |
Microsoft
MSFT
|
$1.04B |
| 2 |
Apple
AAPL
|
$738M |
| 3 |
TSMC
TSM
|
$611M |
| 4 |
Global X Cybersecurity ETF
BUG
|
$521M |
| 5 |
Amazon
AMZN
|
$510M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$522M |
| 2 |
Synchrony
SYF
|
$162M |
| 3 |
Simon Property Group
SPG
|
$28.7M |
| 4 |
First Trust NASDAQ Cybersecurity ETF
CIBR
|
$21.2M |
| 5 |
iShares MSCI South Korea ETF
EWY
|
$18.1M |
Sector Composition
| 1 | Technology | 42.39% |
| 2 | Consumer Discretionary | 12.84% |
| 3 | Communication Services | 12.44% |
| 4 | Consumer Staples | 6.28% |
| 5 | Financials | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JMIA
176
Jumia Technologies
JMIA
$1.09B
| $262K | ﹤0.01% |
7,394
+1,348
| +22% | +$47.8K |
|
177
Pinduoduo
PDD
$177B
| $245K | ﹤0.01% |
1,832
+462
| +34% | +$61.8K |
|
178
GSK
GSK
$81.5B
| $239K | ﹤0.01% |
5,360
| – | – |
|
|
LITB
179
LightInTheBox
LITB
$34M
| $239K | ﹤0.01% |
+14,558
| New | +$239K |
|
180
Sapiens International
SPNS
$2.4B
| $217K | ﹤0.01% |
6,886
+6,313
| +1,102% | +$199K |
|
181
Sarepta Therapeutics
SRPT
$1.96B
| $212K | ﹤0.01% |
2,840
-2,331
| -45% | -$174K |
|
|
SUMO
182
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $206K | ﹤0.01% |
+10,934
| New | +$206K |
|
183
IBM
IBM
$232B
| $200K | ﹤0.01% |
+1,569
| New | +$200K |
|
184
Morningstar
MORN
$10.8B
| $154K | ﹤0.01% |
686
-136
| -17% | -$30.5K |
|
185
Vericel Corp
VCEL
$1.72B
| $136K | ﹤0.01% |
2,452
-1,026
| -29% | -$56.9K |
|
186
Bristol-Myers Squibb
BMY
$96B
| $126K | ﹤0.01% |
1,985
+213
| +12% | +$13.5K |
|
187
Johnson & Johnson
JNJ
$430B
| $125K | ﹤0.01% |
762
+33
| +5% | +$5.41K |
|
188
CRISPR Therapeutics
CRSP
$4.99B
| $122K | ﹤0.01% |
+1,000
| New | +$122K |
|
189
10x Genomics
TXG
$1.74B
| $122K | ﹤0.01% |
673
+77
| +13% | +$14K |
|
190
ResMed
RMD
$40.6B
| $121K | ﹤0.01% |
625
-174
| -22% | -$33.7K |
|
191
DexCom
DXCM
$31.6B
| $120K | ﹤0.01% |
1,336
| – | – |
|
192
Teladoc Health
TDOC
$1.38B
| $118K | ﹤0.01% |
650
+150
| +30% | +$27.2K |
|
193
Mettler-Toledo International
MTD
$26.9B
| $116K | ﹤0.01% |
100
-399
| -80% | -$463K |
|
194
MannKind Corp
MNKD
$1.7B
| $115K | ﹤0.01% |
29,313
+16,039
| +121% | +$62.9K |
|
195
STAAR Surgical
STAA
$1.38B
| $115K | ﹤0.01% |
1,094
-45
| -4% | -$4.73K |
|
196
Texas Instruments
TXN
$171B
| $115K | ﹤0.01% |
608
+248
| +69% | +$46.9K |
|
|
CUTR
197
DELISTED
Cutera, Inc.
CUTR
| $114K | ﹤0.01% |
3,808
+2,213
| +139% | +$66.3K |
|
198
Tactile Systems Technology
TCMD
$300M
| $113K | ﹤0.01% |
+2,076
| New | +$113K |
|
199
AbbVie
ABBV
$375B
| $110K | ﹤0.01% |
1,016
-615
| -38% | -$66.6K |
|
200
Keysight
KEYS
$28.9B
| $106K | ﹤0.01% |
+737
| New | +$106K |
|